<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30647038</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Jan</Month><Day>15</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Global certification of wild poliovirus eradication: insights from modelling hard-to-reach subpopulations and confidence about the absence of transmission.</ArticleTitle><Pagination><StartPage>e023938</StartPage><MedlinePgn>e023938</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e023938</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2018-023938</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To explore the extent to which undervaccinated subpopulations may influence the confidence about no circulation of wild poliovirus (WPV) after the last detected case.</AbstractText><AbstractText Label="DESIGN AND PARTICIPANTS">We used a hypothetical model to examine the extent to which the existence of an undervaccinated subpopulation influences the confidence about no WPV circulation after the last detected case as a function of different characteristics of the subpopulation (eg, size, extent of isolation). We also used the hypothetical population model to inform the bounds on the maximum possible time required to reach high confidence about no circulation in a completely isolated and unvaccinated subpopulation starting either at the endemic equilibrium or with a single infection in an entirely susceptible population.</AbstractText><AbstractText Label="RESULTS">It may take over 3&#x2009;years to reach 95% confidence about no circulation for this hypothetical population despite high surveillance sensitivity and high vaccination coverage in the surrounding general population if: (1) ability to detect cases in the undervaccinated subpopulation remains exceedingly small, (2) the undervaccinated subpopulation remains small and highly isolated from the general population and (3) the coverage in the undervaccinated subpopulation remains very close to the minimum needed to eradicate. Fully-isolated hypothetical populations of 4000 people or less cannot sustain endemic transmission for more than 5 years, with at least 20&#x2009;000 people required for a 50% chance of at least 5 years of sustained transmission in a population without seasonality that starts at the endemic equilibrium. Notably, however, the population size required for persistent transmission increases significantly for realistic populations that include some vaccination and seasonality and/or that do not begin at the endemic equilibrium.</AbstractText><AbstractText Label="CONCLUSIONS">Significant trade-offs remain inherent in global polio certification decisions, which underscore the need for making and valuing investments to maximise population immunity and surveillance quality in all remaining possible WPV reservoirs.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Duintjer Tebbens</LastName><ForeName>Radboud J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Kid Risk, Inc, Columbus, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalkowska</LastName><ForeName>Dominika A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Kid Risk, Inc, Columbus, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Kimberly M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Kid Risk, Inc, Columbus, Ohio, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>01</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003906" MajorTopicYN="N">Developing Countries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060740" MajorTopicYN="Y">Disease Eradication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="N">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="N">Poliomyelitis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000635" MajorTopicYN="Y">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="N">Poliovirus</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073887" MajorTopicYN="N">Vaccination Coverage</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">certification</Keyword><Keyword MajorTopicYN="N">eradication</Keyword><Keyword MajorTopicYN="N">modeling</Keyword><Keyword MajorTopicYN="N">polio</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>1</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30647038</ArticleId><ArticleId IdType="pmc">PMC6340450</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2018-023938</ArticleId><ArticleId IdType="pii">bmjopen-2018-023938</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World HealthAssembly. Global eradication of poliomyelitis by the year 2000 (resolution 41.28. Geneva: World Health Organization, 1988.</Citation></Reference><Reference><Citation>Duintjer Tebbens RJ, Pallansch MA, Kalkowska DA, et al. . Characterizing poliovirus transmission and evolution: insights from modeling experiences with wild and vaccine-related polioviruses. Risk Anal 2013;33:703&#x2013;49. 10.1111/risa.12044</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/risa.12044</ArticleId><ArticleId IdType="pubmed">23521018</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson KM, Pallansch MA, Duintjer Tebbens RJ, et al. . Modeling population immunity to support efforts to end the transmission of live polioviruses. Risk Anal 2013;33:647&#x2013;63. 10.1111/j.1539-6924.2012.01891.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1539-6924.2012.01891.x</ArticleId><ArticleId IdType="pmc">PMC7896539</ArticleId><ArticleId IdType="pubmed">22985171</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson KM, Kalkowska DA, Duintjer Tebbens RJ. Managing population immunity to reduce or eliminate the risks of circulation following the importation of polioviruses. Vaccine 2015;33:1568&#x2013;77. 10.1016/j.vaccine.2015.02.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.02.013</ArticleId><ArticleId IdType="pmc">PMC7907970</ArticleId><ArticleId IdType="pubmed">25701673</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson KM, Duintjer Tebbens RJ. The case for cooperation in managing and maintaining the end of poliomyelitis: stockpile needs and coordinated OPV cessation. Medscape J Med 2008;10:190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2562150</ArticleId><ArticleId IdType="pubmed">18924642</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Global polio eradication initiative: polio eradication and endgame strategic plan (2013-2018). Geneva: World Health Organization, 2013.</Citation></Reference><Reference><Citation>World Health Assembly. Poliomyelitis: mechanism for management of potential risks to eradication (resolution 61.1. Geneva: World Health Organization, 2008.</Citation></Reference><Reference><Citation>
Global Polio Eradication Initiative. Global eradication of wild poliovirus type 2 declared 2015. 2015. 
http://www.polioeradication.org/mediaroom/newsstories/Global-eradication-of-wild-poliovirus-type-2-declared/tabid/526/news/1289/Default.aspx (Accessed 30 Nov 2015).</Citation></Reference><Reference><Citation>Hampton LM, Farrell M, Ramirez-Gonzalez A, et al. . Cessation of trivalent oral poliovirus vaccine and introduction of inactivated poliovirus vaccine - worldwide, 2016. MMWR Morb Mortal Wkly Rep 2016;65:934&#x2013;8. 10.15585/mmwr.mm6535a3</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6535a3</ArticleId><ArticleId IdType="pubmed">27606675</ArticleId></ArticleIdList></Reference><Reference><Citation>
World Health Organization. Polio this week as of 2018. 2018. 
http://polioeradication.org/polio-today/polio-now/this-week/
</Citation></Reference><Reference><Citation>Kew OM, Cochi SL, Jafari HS, et al. . Possible eradication of wild poliovirus type 3--worldwide, 2012. MMWR Morb Mortal Wkly Rep 2014;63:1031&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5779498</ArticleId><ArticleId IdType="pubmed">25393222</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Laboratory surveillance for wild and vaccine-derived polioviruses, January 2004-June 2005. Weekly Epidemiological Record 2005;80:335&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Nnadi C, Damisa E, Esapa L, et al. . Continued endemic wild poliovirus transmission in security-compromised areas - Nigeria, 2016. MMWR Morb Mortal Wkly Rep 2017;66:190&#x2013;3. 10.15585/mmwr.mm6607a2</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6607a2</ArticleId><ArticleId IdType="pmc">PMC5657850</ArticleId><ArticleId IdType="pubmed">28233765</ArticleId></ArticleIdList></Reference><Reference><Citation>Nathanson N, Kew OM. From emergence to eradication: the epidemiology of poliomyelitis deconstructed. Am J Epidemiol 2010;172:1213&#x2013;29. 10.1093/aje/kwq320</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwq320</ArticleId><ArticleId IdType="pmc">PMC2991634</ArticleId><ArticleId IdType="pubmed">20978089</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Transmission of wild poliovirus type 2--apparent global interruption. Wkly Epidemiol Rec 2001;76:95&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">11315462</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshpande JM, Nadkarni SS, Siddiqui ZA. Detection of MEF-1 laboratory reference strain of poliovirus type 2 in children with poliomyelitis in India in 2002 &amp; 2003. Indian J Med Res 2003;118:217&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">14870793</ArticleId></ArticleIdList></Reference><Reference><Citation>Duizer E, Ruijs WL, van der Weijden CP, et al. . Response to a wild poliovirus type 2 (WPV2)-shedding event following accidental exposure to WPV2, the Netherlands, April 2017. Euro Surveill 2017;22 10.2807/1560-7917.ES.2017.22.21.30542</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2017.22.21.30542</ArticleId><ArticleId IdType="pmc">PMC5479986</ArticleId><ArticleId IdType="pubmed">28597830</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC). Certification of poliomyelitis eradication--the Americas, 1994. MMWR Morb Mortal Wkly Rep 1994;43:720&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">7522302</ArticleId></ArticleIdList></Reference><Reference><Citation>Debanne SM, Rowland DY. Statistical certification of eradication of poliomyelitis in the Americas. Math Biosci 1998;150:83&#x2013;103. 10.1016/S0025-5564(98)00007-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0025-5564(98)00007-8</ArticleId><ArticleId IdType="pubmed">9654894</ArticleId></ArticleIdList></Reference><Reference><Citation>Eichner M, Dietz K. Eradication of poliomyelitis: when can one be sure that polio virus transmission has been terminated? Am J Epidemiol 1996;143:816&#x2013;22. 10.1093/oxfordjournals.aje.a008820</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a008820</ArticleId><ArticleId IdType="pubmed">8610692</ArticleId></ArticleIdList></Reference><Reference><Citation>Eichner M, Hadeler KP. Deterministic models for the eradication of poliomyelitis: vaccination with the inactivated (IPV) and attenuated (OPV) polio virus vaccine. Math Biosci 1995;127:149&#x2013;66. 10.1016/0025-5564(94)00046-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0025-5564(94)00046-3</ArticleId><ArticleId IdType="pubmed">7795316</ArticleId></ArticleIdList></Reference><Reference><Citation>Eichner M, Hadeler KP, Dietz K. Stochastic models for the eradication of poliomyelitis: minimum population size for polio virus persistence : Isham V, Medley GF, Models for Infectious human diseases: their structure and relation to data.. New York: Cambridge University Press, 1996:315&#x2013;27.</Citation></Reference><Reference><Citation>World Health Organization. Global polio eradication initiative: strategic plan 2004-2008. Geneva: World Health Organization, 2004.</Citation></Reference><Reference><Citation>Bahl S, Kumar R, Menabde N, et al. . Polio-free certification and lessons learned--South-East Asia region, March 2014. MMWR Morb Mortal Wkly Rep 2014;63:941&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5779468</ArticleId><ArticleId IdType="pubmed">25340910</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalkowska DA, Duintjer Tebbens RJ, Thompson KM. The probability of undetected wild poliovirus circulation after apparent global interruption of transmission. Am J Epidemiol 2012;175:936&#x2013;49. 10.1093/aje/kwr399</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwr399</ArticleId><ArticleId IdType="pubmed">22459121</ArticleId></ArticleIdList></Reference><Reference><Citation>Houy N. The probability of undetected wild poliovirus circulation: Can we do better? J Theor Biol 2015;382:272&#x2013;8. 10.1016/j.jtbi.2015.06.046</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtbi.2015.06.046</ArticleId><ArticleId IdType="pubmed">26165452</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalkowska DA, Duintjer Tebbens RJ, Pallansch MA, et al. . Modeling undetected live poliovirus circulation after apparent interruption of transmission: implications for surveillance and vaccination. BMC Infect Dis 2015;15:1 10.1186/s12879-015-0791-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-015-0791-5</ArticleId><ArticleId IdType="pmc">PMC4344758</ArticleId><ArticleId IdType="pubmed">25886823</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalkowska DA, Duintjer Tebbens RJ, Thompson KM. Modeling strategies to increase population immunity and prevent poliovirus transmission in 2 high-risk areas in northern India. J Infect Dis 2014;210:S398&#x2013;411. 10.1093/infdis/jit844</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jit844</ArticleId><ArticleId IdType="pubmed">25316861</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalkowska DA, Duintjer Tebbens RJ, Thompson KM. Modeling strategies to increase population immunity and prevent poliovirus transmission in the high-risk area of northwest Nigeria. J Infect Dis 2014;210:S412&#x2013;23. 10.1093/infdis/jit834</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jit834</ArticleId><ArticleId IdType="pubmed">25316863</ArticleId></ArticleIdList></Reference><Reference><Citation>Duintjer Tebbens RJ, Kalkowska DA, Wassilak SGF, et al. . The potential impact of expanding target age groups for polio immunization campaigns. BMC Infect Dis 2014;14:45 10.1186/1471-2334-14-45</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-14-45</ArticleId><ArticleId IdType="pmc">PMC3918103</ArticleId><ArticleId IdType="pubmed">24472313</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalkowska DA, Duintjer Tebbens RJ, Grotto I, et al. . Modeling options to manage type 1 wild poliovirus imported into Israel in 2013. J Infect Dis 2015;211:1800&#x2013;12. 10.1093/infdis/jiu674</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiu674</ArticleId><ArticleId IdType="pmc">PMC7887763</ArticleId><ArticleId IdType="pubmed">25505296</ArticleId></ArticleIdList></Reference><Reference><Citation>Berchenko Y, Manor Y, Freedman LS, et al. . Estimation of polio infection prevalence from environmental surveillance data. Sci Transl Med 2017;9:eaaf6786 10.1126/scitranslmed.aaf6786</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaf6786</ArticleId><ArticleId IdType="pubmed">28356510</ArticleId></ArticleIdList></Reference><Reference><Citation>Famulare M. Has Wild Poliovirus Been Eliminated from Nigeria? PLoS One 2016;10:e0135765 10.1371/journal.pone.0135765</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0135765</ArticleId><ArticleId IdType="pmc">PMC4552877</ArticleId><ArticleId IdType="pubmed">26317401</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallejo C, Keesling J, Koopman J, et al. . Silent circulation of poliovirus in small populations. Infect Dis Model 2017;2:431&#x2013;40. 10.1016/j.idm.2017.11.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idm.2017.11.001</ArticleId><ArticleId IdType="pmc">PMC6001964</ArticleId><ArticleId IdType="pubmed">30137721</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallejo C, Keesling J, Koopman JS, et al. . Corrigendum to&#xa0;&#x201c;Silent circulation of poliovirus in small populations&#x201d;. Infectious Disease Modelling 2018;3:136&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6326216</ArticleId><ArticleId IdType="pubmed">30839888</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalkowska DA, Duintjer Tebbens RJ, Thompson KM. Another look at silent circulation of poliovirus in small populations. Infectious Disease Modelling 2018;3:107&#x2013;17. 10.1016/j.idm.2018.06.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idm.2018.06.001</ArticleId><ArticleId IdType="pmc">PMC6326228</ArticleId><ArticleId IdType="pubmed">30839913</ArticleId></ArticleIdList></Reference><Reference><Citation>
World Health Organization. Report on polio transition planning - advance draft as of 18 April, 2017. 2017. 
http://www.who.int/mediacentre/events/2017/advance-report-polio-transmission.pdf?ua=1 (Accessed 12 March 2018).</Citation></Reference><Reference><Citation>Thompson KM, Duintjer Tebbens RJ. Lessons from the polio endgame: overcoming the failure to vaccinate and the role of subpopulations in maintaining transmission. J Infect Dis 2017;216(suppl_1):S176&#x2013;S182. 10.1093/infdis/jix108</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jix108</ArticleId><ArticleId IdType="pmc">PMC5853387</ArticleId><ArticleId IdType="pubmed">28838194</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillespie DT. A general method for numerically simulating the stochastic time evolution of coupled chemical reactions. J Comput Phys 1976;22:403&#x2013;34. 10.1016/0021-9991(76)90041-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0021-9991(76)90041-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterman J. Business dynamics: Systems thinking and modeling for a complex world. Boston, MA: McGraw-Hill, 2000.</Citation></Reference><Reference><Citation>Duintjer Tebbens RJ, Pallansch MA, Cochi SL, et al. . Modeling poliovirus transmission in pakistan and afghanistan to inform vaccination strategies in undervaccinated subpopulations. Risk Anal 2018;38:1701&#x2013;17. 10.1111/risa.12962</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/risa.12962</ArticleId><ArticleId IdType="pmc">PMC7879700</ArticleId><ArticleId IdType="pubmed">29314143</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Polio Eradication Initiative. Guidelines on environmental surveillance for detection of polioviruses - working draft. 2015.</Citation></Reference><Reference><Citation>Duintjer Tebbens RJ, Zimmermann M, Pallansch MA, et al. . Insights from a systematic search for information on designs, costs, and effectiveness of poliovirus environmental surveillance systems. Food Environ Virol 2017;9:361&#x2013;82. 10.1007/s12560-017-9314-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12560-017-9314-4</ArticleId><ArticleId IdType="pmc">PMC7879701</ArticleId><ArticleId IdType="pubmed">28687986</ArticleId></ArticleIdList></Reference><Reference><Citation>Anis E, Kopel E, Singer SR, et al. . Insidious reintroduction of wild poliovirus into Israel, 2013. Euro Surveill 2013;18:20586 10.2807/1560-7917.ES2013.18.38.20586</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES2013.18.38.20586</ArticleId><ArticleId IdType="pubmed">24084337</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalkowska DA, Duintjer Tebbens RJ, Thompson KM. Environmental surveillance system characteristics and impacts on confidence about no undetected serotype 1 wild poliovirus circulation. Risk Anal 2018;62 10.1111/risa.13193</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/risa.13193</ArticleId><ArticleId IdType="pmc">PMC7857156</ArticleId><ArticleId IdType="pubmed">30239023</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson KM, Wallace GS, Tebbens RJ, et al. . Trends in the risk of U.S. polio outbreaks and poliovirus vaccine availability for response. Public Health Rep 2012;127:23&#x2013;37. 10.1177/003335491212700104</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/003335491212700104</ArticleId><ArticleId IdType="pmc">PMC3234395</ArticleId><ArticleId IdType="pubmed">22298920</ArticleId></ArticleIdList></Reference><Reference><Citation>Duintjer Tebbens RJ, Thompson KM. Polio endgame risks and the possibility of restarting the use of oral poliovirus vaccine. Expert Rev Vaccines 2018;17:739&#x2013;51. 10.1080/14760584.2018.1506333</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14760584.2018.1506333</ArticleId><ArticleId IdType="pmc">PMC6168953</ArticleId><ArticleId IdType="pubmed">30056767</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>